Skip to main content
. 2019 Aug 22;9(2):195–218. doi: 10.1016/j.jcmgh.2019.08.004

Figure 11.

Figure 11

Nivolumab therapy affects CD8+T-cell phenotype. (A) tSNE map of CD8+ T cells from TILs (yellow dots), NTILs (purple dots), and PBMCs (green dots) of pretreated and on-therapy HCC patients. (B) tSNE maps showing the expression level and the distribution of each indicated marker. Color scale indicates the relative expression levels.